2370013-49-1

2370013-49-1 structure
2370013-49-1 structure
  • Name: (S)-Sunvozertinib
  • Chemical Name: DZD9008
  • CAS Number: 2370013-49-1
  • Molecular Formula: C29H35ClFN7O3
  • Molecular Weight: 584.08
  • Catalog: Signaling Pathways JAK/STAT Signaling EGFR
  • Create Date: 2021-09-12 08:24:30
  • Modify Date: 2024-01-06 11:26:08
  • (S)-Sunvozertinib ((S)-DZD9008), the S-enantiomer of Sunvozertinib, shows inhibitory activity against EGFR exon 20 NPH and ASV insertions, EGFR L858R/T790M mutation and Her2 exon20 YVMA insertion (IC50=51.2 nM, 51.9 nM, 1 nM, and 21.2 nM, respectively). (S)-Sunvozertinib also inhibits BTK[1].

Name DZD9008
Synonyms 2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]-
Description (S)-Sunvozertinib ((S)-DZD9008), the S-enantiomer of Sunvozertinib, shows inhibitory activity against EGFR exon 20 NPH and ASV insertions, EGFR L858R/T790M mutation and Her2 exon20 YVMA insertion (IC50=51.2 nM, 51.9 nM, 1 nM, and 21.2 nM, respectively). (S)-Sunvozertinib also inhibits BTK[1].
Related Catalog
Target

EGFR exon 20 NPH:51.2 nM (IC50)

EGFR exon 20 ASV insertion:51.9 nM (IC50)

EGFRL858R/T790M:1 nM (IC50)

Her2 exon 20 YVMA insertion:21.2 nM (IC50)

In Vitro (S)-Sunvozertinib shows proliferation inhibition of Ba/F3 EGFR NPH ins (GI50=139.7 nM), Ba/F3 FGFR ASV ins (155.7 nM), NCI-HI975 EGFRL858R/T790M (24.4), Her2 YVMA ins (827 nM) and WT EGFR (84.8 nM)[1]. (S)-Sunvozertinib shows proliferation inhibition of BTK WT cells (OCI-LY-10, TMD-8, Ri-1and DB, with GI50 ranging from 13.7-48 nM)[1].
References

[1]. Zhengtao LI, et al. Erbb/btk inhibitors. WO2019149164A1.

Molecular Formula C29H35ClFN7O3
Molecular Weight 584.08
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.